A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies

Clinical trial NCT03999697 · UNKNOWN

Trial details

NCT number: NCT03999697
Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Follicular Lymphoma Primary Cutaneous Follicle Centre Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Mantle Cell Lymphoma Plasma Cell Neoplasm B Cell Lymphoma

Start date: 2018-12-01
Primary completion: 2020-12-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.